Resources

Szilard Voros, MD, FACC, FSCCT, FAHA, explains that the new Diabetes Prevention & Management Panel test from Health Diagnostic Laboratory is comprehensive enough to easily identify not only whether a patient is type 1 or 2 but also 1.5, and other diabetes variants….

Szilard Voros, MD, tells us how long the new DPMP (Diabetes Prevention & Management Panel) test from Health Diagnostic Laboratory has been available. Most of the work until recently was focused on cardiovascular disease but the team realized that diabetes was so connected that they are now doing tests for …

Szilard Voros, MD, talks about the new DPMP test and how it can diagnose pre-prediabetes, out-performing many existing tests. Dr. Voros also says that most people are unaware of the new test but that the team is working to get the word out on these incredibly accurate new tests. Other …

Szilard Voros, MD, tells us how the test developed by Health Diagnostic Laboratory, the Diabetes Prevention & Management Panel (DPMP) is done and how quickly results can be returned. Other videos with Dr. Voros: Szilard Voros, MD, FACC, FSCCT, FAHA: Introduction New Panel of Tests (DPMP) Identifies Diabetes and CV Risk …

Szilard Voros, MD, explains that the new DPMP test data is presented to clinicians and includes analysis as well as the data. The team spent 18 months gathering the components of the tests and always wanted the panel to be actionable so treatment recommendations are also included as well as …

Szilard Voros, MD, talks about the three factors that are included in the DPMP test and how they overlap but are separate from the CV data reports. Other videos with Dr. Voros: Szilard Voros, MD, FACC, FSCCT, FAHA: Introduction New Panel of Tests (DPMP) Identifies Diabetes and CV Risk Earlier …

Szilard Voros, MD, talks about the DPMP test that Health Diagnostics Laboratory has developed and how the insurance companies are handling the new tests. Other videos with Dr. Voros: Szilard Voros, MD, FACC, FSCCT, FAHA: Introduction New Panel of Tests (DPMP) Identifies Diabetes and CV Risk Earlier Beta-cell Dysfunction Not …

Szilard Voros, MD, discusses the drug Cycloset (a central dopamine agonist) and its possibilities for improving both cardiovascular and diabetic health. He talks about how Health Diagnostics Laboratory sees a very specific role and niche for this particular drug because of a specific biomarker they have identified. Other videos with Dr. …

  Szilard Voros, MD, discusses what he found the most interesting at the 2013 ADA and singles out the new SGLT2 inhibitor class of drugs as especially exciting. However, he cautions that they are very new and only time will tell regarding any safety aspects. He is intrigued by the concept …

Szilard Voros, MD, talks about one of the most surprising aspects of the DPMP testing. Several hundred patients participated initially with their providers. The baseline panel results were given to their doctors who used the results to work with their patients. After the second test, results indicated that around a …